Skip to main content
EcoSphere News
HealthNigeria

Nigeria Launches Life-Saving Malaria Vaccine Amid Record Deaths

Nigeria introduces R21/Matrix-M malaria vaccine, aiming to curb the world's highest malaria death toll.

Source: bbc.co.uk2 min read
Nigeria Launches Life-Saving Malaria Vaccine Amid Record Deaths
Image via bbc.co.uk

In brief

With a staggering 27% of global cases, Nigeria's initiative marks a crucial step towards combatting malaria, particularly among vulnerable populations.

Nigeria is now on the frontline in the battle against malaria, rolling out the R21/Matrix-M vaccine in response to the country’s grave public health crisis. As the nation grapples with the highest malaria mortality worldwide, this initiative seeks to protect children aged between five and 15 months from a disease that accounts for a significant share of annual deaths.With nearly a third of malaria-related casualties occurring in Nigeria, experts have long cited the urgency of effective intervention. The R21/Matrix-M vaccine, recently approved by the World Health Organization (WHO), boasts a promising 75% efficacy. However, health authorities emphasize its use in conjunction with traditional prevention methods, such as mosquito nets and insecticides, to optimize protection against the disease.The initial rollout commenced in Bayelsa and Kebbi states, both significantly impacted by malaria, with plans for nationwide distribution by next year. At the inaugural vaccination event in Bayelsa, proud mother Happiness Idia-Wilson declared her commitment to child safety as she witnessed her 11-month-old son become the first recipient of the vaccine. She urged other parents to consider vaccination as a critical option for safeguarding their children's health.Bayelsa's health commissioner, Prof. Seiyefa Brisibe, announced the enforcement of health campaigns tailored to various local languages to enhance awareness about the vaccine. Data from the WHO highlights that Nigeria accounted for 27% of all global malaria cases and 31% of malaria deaths in 2022, with children under five and pregnant women being the most at-risk demographics. Alarmingly, the region of Africa collectively sees 95% of the global malaria fatalities, underscoring the critical need for preventive action.Dr. Walter Mulombo, WHO representative in Nigeria, expressed optimism that the introduction of this vaccine alongside other health measures will significantly lower malaria's toll, rallying towards a malaria-free future in Africa. The financial toll of malaria in Nigeria is equally alarming, with an estimated $1.1 billion lost annually due to health costs and productivity losses related to the disease.Developed by the Jenner Institute at Oxford University, the R21/Matrix-M vaccine is administered in a series of three doses over a span of four weeks, followed by a booster shot after one year. Earlier this year, similar initiatives were launched in neighboring countries, including Ivory Coast and the Democratic Republic of Congo, contributing to a collective effort against malaria on the continent. This pivotal development in Nigeria showcases the importance of leveraging healthcare innovations to combat environmental and health challenges directly tied to global climate issues.

Topics

More on this story